PDS Biotechnology Corp. (PDSB)
1.165
+0.14
(+13.11%)
USD |
NASDAQ |
May 21, 16:00
1.165
0.00 (0.00%)
After-Hours: 19:00
PDS Biotechnology Shareholders Equity (Quarterly) : 3.893M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Altimmune, Inc. | 283.99M |
| INmune Bio, Inc. | 19.62M |
| Humacyte, Inc. | 11.62M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.66M |
| Total Liabilities (Quarterly) | 20.77M |
| Debt to Equity Ratio | 4.075 |
| Current Ratio | 2.256 |
| Net Debt Paydown Yield | 3.53% |